News
CloudCath raises funds towards peritoneal dialysis monitoring system
Digital health medical device company CloudCath has completed a $12m Series A funding round to commercialise a system that enables remote and live monitoring...
Press Releases
TransEnterix Announces CE Mark Approval for Pediatric Indication for Senhance Surgical System
TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced...
Press Releases
Philips to study outcomes of PCI guided by iFR and X-ray images
Royal Philips , a global leader in health technology, announced a new randomized controlled trial to assess patient outcomes after receiving a percutaneous coronary...
Press Releases
Medtronic to Advance Solutions and Capabilities in Surgical Data and Analytics with Acquisition of Digital Surgery
Medtronic plc , the global leader in medical technology, announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data...
Press Releases
Q BioMed Launches Non-Opioid Treatment for Metastatic Bone Pain
Q BioMed Inc. , a commercial stage biotech company, announced the launch of its FDA approved non-opioid drug Strontium89 (Strontium Chloride Sr-89 Injection, USP),...
Press Releases
Industry-First Bedside MRI Secures FDA Clearance
Inpatients around the United States could soon experience the convenience of having an MRI scan without leaving their hospital rooms. The U.S. Food &...
Research Insight
Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohns Disease
Takeda Pharmaceutical Company Limited announced results from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read